TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive In Brief: Shingleton Chairs Cancer Control Committee; Joftes, Price Head Review, Organ Site Branches September 3, 1976
TCL Archive FDA Blocks Nine More INDs; Cooperative Group Chairmen, DeVita Blast “Lack of Expertise” January 7, 1977
